u/ice_pack_audit

Half-life is about 168 hours, so steady state lands around week 22–5. Practical consequence: what you feel in week 1 is not what that dose does.

a warm courier van is a bigger problem for a mixed vial than for dry powder

consistency is harder than the dose change

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

the BPC-157 literature looks promising but rodent-only

the tier 3 pathway is the only free route, it is slow

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

Homopeptide Canada to Canada: 15 days with Homopeptide shipping, 14 days with customs. No drama.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

Removed a chain here. The rule is one line long and it is not negotiable.

This is correct. The co-agonism is real.

consistency is harder than the dose change

Titration speed is a side-effect dial far more than an efficacy dial.

What are you comparing it against though?

the community lane table lives here

Strongly agree. A1c matters as much as weight.

small molecule, not a peptide, purity discussion is different

long-acting amylin is co-agonism, different satiety profile

handlers in the community are rare and cautious